Morgan Stanley has filed an S‑1 with the SEC to launch a spot Bitcoin ($BTC) ETF, alongside a separate Solana ($SOL) trust, signaling another major Wall Street institution expanding its footprint in digital assets.Morgan Stanley has filed an S‑1 with the SEC to launch a spot Bitcoin ($BTC) ETF, alongside a separate Solana ($SOL) trust, signaling another major Wall Street institution expanding its footprint in digital assets.
Morgan Stanley Files S‑1 to Launch Spot Bitcoin ETF and Separate Solana Trust
뉴스 요약
Morgan Stanley has filed an S‑1 with the SEC to launch a spot Bitcoin ($BTC) ETF, alongside a separate Solana ($SOL) trust, signaling another major Wall Street institution expanding its footprint in digital assets.
Summary
Morgan Stanley has filed an S‑1 with the SEC to launch a spot Bitcoin ($BTC) ETF, alongside a separate Solana ($SOL) trust, signaling another major Wall Street institution expanding its footprint in digital assets.
What’s Included in the Filing
- Product 1: Spot Bitcoin ETF
- Product 2: Solana trust (separate vehicle)
- Regulator: U.S. Securities and Exchange Commission (SEC)
- Stage: Initial S‑1 registration filing
An S‑1 filing is the formal first step toward bringing these products to market, though approval timelines remain uncertain.
Why This Matters
- Institutional validation: Morgan Stanley joining the spot ETF race reinforces Bitcoin’s place in mainstream portfolios
- Broader crypto exposure: A Solana trust expands institutional access beyond BTC and ETH
- Competitive pressure: Adds to the growing lineup of traditional asset managers offering crypto products
- Capital access: Makes crypto exposure available through familiar, regulated vehicles
Market Implications
- Could increase institutional inflows if approved
- Strengthens Bitcoin’s role as a core digital asset
- Highlights rising demand for regulated access to alternative L1s like Solana
Bottom Line
Morgan Stanley’s S‑1 filing for a spot Bitcoin ETF and a Solana trust marks another step in Wall Street’s steady embrace of crypto. If approved, these products would further integrate digital assets into traditional investment portfolios.
시장 기회
Intuition 가격(TRUST)
$0.07361
$0.07361$0.07361
USD
Intuition (TRUST) 실시간 가격 차트
면책 조항: 본 페이지에 게시된 글은 독립적인 기고자가 작성한 것으로, 반드시 MEXC의 공식 입장을 반영하는 것은 아닙니다. 모든 콘텐츠는 정보 제공 및 교육 목적으로만 제공되며, 제공된 정보를 바탕으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다. 암호화폐 시장은 매우 변동성이 높습니다. 투자 결정을 내리기 전에 반드시 자체 조사를 수행하고 자격을 갖춘 금융 전문가와 상담하시기 바랍니다.
추천 콘텐츠
The Silver Price Doesn’t Look Real – And This Video Explains Why
The Silver (XAG) price has been acting strange lately. Just when it looked like the market was settling down, a new argument started spreading fast: silver might
공유하기
Captainaltcoin2026/02/11 04:00
Will XRP Price Increase In September 2025?
Ripple XRP is a cryptocurrency that primarily focuses on building a decentralised payments network to facilitate low-cost and cross-border transactions. It’s a native digital currency of the Ripple network, which works as a blockchain called the XRP Ledger (XRPL). It utilised a shared, distributed ledger to track account balances and transactions. What Do XRP Charts Reveal? […]
공유하기
Tronweekly2025/09/18 00:00
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves
The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
공유하기
BitcoinEthereumNews2025/09/18 03:11